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The first influenza pandemic of the new millennium was caused by a newly emerged swine-origin influenza
virus (SOIV) (H1N1). This new virus is characterized by a previously unknown constellation of gene segments
derived from North American and Eurasian swine lineages and the absence of common markers predictive of
human adaptation. Overall, human infections appeared to be mild, but an alarming number of young indi-
viduals presented with symptoms atypical for seasonal influenza. The new SOIV also showed a sustained
human-to-human transmissibility and higher reproduction ratio than common seasonal viruses, altogether
indicating a higher pathogenic potential for this newly emerged virus. To study the virulence of the SOIV, we
used a recently established cynomolgus macaque model and compared parameters of clinical disease, virology,
host responses, and pathology/histopathology with a current seasonal H1N1 virus. We here show that infection
of macaques with two genetically similar but clinically distinct SOIV isolates from the early stage of the
pandemic (A/Mexico/4108/2009 and A/Mexico/InDRE4487/2009) resulted in upper and lower respiratory tract
infections and clinical disease ranging from mild to severe pneumonia that was clearly advanced over the mild
infection caused by A/Kawasaki/UTK-4/2009, a current seasonal strain. Unexpectedly, we observed heteroge-
neity among the two SOIV isolates in virus replication, host transcriptional and cytokine responses, and
disease progression, demonstrating a higher pathogenic potential for A/Mexico/InDRE4487/2009. Differences
in virulence may explain more severe disease, as was seen with certain individuals infected with the emerged
pandemic influenza virus. Thus, the nonhuman primate model closely mimics influenza in humans.
A newly emerged swine-origin influenza virus (SOIV)
(H1N1) caused the first influenza pandemic of the 21st century
(1, 9). Sequence comparison revealed a unique virus with gene
segments derived from North American and Eurasian swine
lineages and the absence of any known markers predictive of
human adaptation (10, 36), with the exception of a second-site
suppressor mutation in PB2 (23). In general, human SOIV
infections appear to be mild; however, some infected individ-
uals presented with symptoms atypical for seasonal influenza,
and more severe illness has been reported in young, previously
healthy individuals (6, 11, 28, 30). This suggests that the new
pandemic H1N1 virus is distinct from common seasonal influ-
enza viruses. However, the actual pathogenic potential of the
circulating virus pool remains unknown.
The pathogenic potential of human influenza viruses is often
studied in mice and ferrets, although human H1N1 influenza
viruses normally replicate efficiently in mice only after adap-
tation (13). In contrast, the SOIV isolates replicate efficiently
in mouse lung and some isolates produce severe and even
lethal infection under high-dose application (17, 22). Ferrets
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are highly susceptible to infection with human influenza viruses
and appear to better recapitulate human disease severity and
transmissibility than mouse models (22, 24). As with mice,
SOIV isolates replicate more efficiently in ferrets compared to
currently circulating H1N1 isolates. However, higher transmis-
sibility of SOIV in ferrets could not be conclusively demon-
strated (17, 20, 22, 24).
Nonhuman primate models have been less extensively used
in influenza research but are often thought to best impersonate
human infectious diseases. In general, human influenza A vi-
ruses infect and replicate in the upper respiratory tract of
macaques, causing either asymptomatic or mild clinical infec-
tions in these animals (2, 3). The exceptions are avian H5N1 (5,
31) and the 1918 H1N1 virus (18), the latter of which causes a
severe/lethal acute respiratory distress syndrome (ARDS) in
cynomolgus macaques that required euthanasia of the animals
(18). Thus far, only two published studies have investigated the
pathogenic potential of the newly emerged H1N1 pandemic
virus in macaques (16, 17). In both studies, a single isolate
(A/California/04/2009 [12, 17] or A/Netherlands/602/2009 [16])
showed efficient replication in the lungs leading to more severe
lung pathology than seasonal H1N1, further suggesting that a
higher pathogenic potential is associated with SOIV compared
to other currently circulating H1N1 viruses (16, 17).
To better understand SOIV pathogenesis, we compared two
genetically similar but clinically distinct Mexican isolates from
the early stage of the pandemic in a macaque challenge model
(18). We found that, in contrast to a current seasonal H1N1
virus, both SOIV isolates replicated in the upper and lower
respiratory tract but differed in their clinical disease manifes-
tation ranging from mild to severe pneumonia. The isolates
showed striking heterogeneity in the extent of virus replica-
tion, host responses, and disease progression. This indicates
concurrent circulation of strains with different pathogenic
potential and thus explaining the distinct clinical picture for
infected individuals.
MATERIALS AND METHODS
Viruses. A/Mexico/4108/2009 (H1N1) (Mex4108) was isolated from a clinical
specimen (kindly provided by the Centers for Disease Control and Prevention,
Influenza Branch) obtained from a 4-year-old boy from Mexico who was mildly
ill. A/Mexico/InDRE4487/2009 (H1N1) (Mex4487) was isolated from the bron-
chial aspirate of a 26-year-old man from a family cluster of three confirmed
severe cases in Mexico (20). A/Kawasaki/UTK-4/2009 (H1N1) (Kaw) was iso-
lated from a human and represents a recent seasonal virus (17). The viruses were
grown in MDCK cells, harvested at a cytopathogenic effect of 3 (70%
rounded off and detached cells) for virus stock preparation, and titrated by using
a 50% tissue culture infective dose (TCID50) assay on MDCK cells. The
Mex4108, Mex4487, and Kaw infections were done with MDCK passage num-
bers 3, 2, and 2, respectively. All infectious work with the SOIVs was done under
enhanced BSL3 conditions in the Integrated Research Facility of the Rocky
Mountain Laboratories (RML), National Institute of Allergy and Infectious
Disease (NIAID), National Institutes of Health (NIH).
In vitro infection (A549 cells). Freshly seeded monolayer of A549 cells were
infected with the different H1N1 virus isolates with 104 TCID50/100 l/well.
Following an adsorption of 1 h at 37°C, unbound viruses were washed away, and
1 ml of minimal essential medium (MEM) supplemented with 0.35 g of TPCK
(tolylsulfonyl phenylalanyl chloromethyl ketone)-trypsin/ml was added to the
cultures. The cells were incubated at 37°C, and supernatants were collected at 12,
24, 48, and 72 h postinfection. Virus titration was performed by using a TCID50
assay on MDCK cells.
In vivo infection (cynomolgus macaques). Twenty-one cynomolgus macaques
(Macaca fascicularis), 4 to 15 years old, weighing 3.0 to 8.7 kg, were evenly
distributed with regard to age and weight over the different groups and infected
with either Mex4108 (n 6), Mex4487 (n 9), or Kaw (n 6) under anesthesia
through a combination of intratracheal (4 ml), intranasal (0.5 ml per nostril),
conjunctival (0.5 ml per eyelid), and oral (1 ml) routes with a suspension con-
taining 106 TCID50/ml (the total infectious dose was 7  106 TCID50) (18). The
animals were monitored daily for clinical signs using an approved scoring sheet
(fever, posture, respiration, feces/urine, food intake, recumbence, attitude, and
skin turgor). On days 2, 0, 1, 3, 6, 8, 11, and 14 postinfection the animals were
examined under anesthesia, at which point X-ray, pulse rate, blood pressure,
temperature, and respiration rate were taken, and each animal was bled for
blood chemistry analysis, differential blood count, virology, and cytokine profiles.
Two (Mex4108) or three (Mex4487, Kaw) animals were euthanized and necrop-
sied on days 1, 6, and 14 postinfection (Kaw only on days 1 and 6) with collection
of clinical specimens from nasal mucosa, oral mucosa, conjunctiva, tonsils, cer-
vical lymph nodes, trachea, bronchi, right and left lungs (upper, middle, and
caudal), hilar lymph nodes, heart, liver, spleen, pancreas, jejunum, transverse
colon, kidney, adrenal gland, and mesenteric lymph nodes. All animal experi-
ments were approved by the RML Institutional Animal Care and Use Commit-
tee (IACUC) and performed according to the guidelines of the Association
for Assessment and Accreditation of Laboratory Animal Care, International
(AAALAC) by certified staff in an AAALAC-approved facility.
Radiographic imaging and gross pathology scoring. X-ray images were scored
blindly according to the following scheme: grade 0, normal examination; grade 1,
mild interstitial pulmonary infiltrates; grade 2, moderate interstitial pulmonary
infiltrates, possibly including partial cardiac border effacement and small areas of
pulmonary consolidation; and grade 3, pulmonary consolidation as primary lung
pathology, often seen as progression from grade 2 lung pathology. The percent-
age of affected lung area was assessed in all lung lobes during necropsy by
macroscopic examination.
Hematology and serum biochemistry. The total white blood cell (WBC) count,
lymphocyte, platelet, reticulocyte, and red blood cell counts, hemoglobin, he-
matocrit values, mean cell volume, mean corpuscular volume, and mean corpus-
cular hemoglobin concentrations were determined from EDTA blood with the
HemaVet 950FS laser-based hematology analyzer (Drew Scientific, Water-
bury, CT). Plasma biochemistry was analyzed from heparin blood by using the
blood chemistry analyzer iSTAT1 (Abbott Point of Care, Princeton, NJ). Urea
nitrogen (BUN), glucose, chloride, sodium, potassium, hematocrit, hemoglobin,
pH, PCO2, TCO2, base excess (BEecf), and anion gap values were determined by
using an EC8 cartridge. Creatinine values were evaluated by using Crea car-
tridges.
Plasma cytokine analysis. Concentrations of granulocyte colony-stimulating
factor, granulocyte-macrophage colony-stimulating factor, gamma interferon,
interleukin-1 (IL-1), IL-4, IL-5, IL-6, IL-8, IL-17, monocyte chemotactic pro-
tein 1 (MCP-1), and macrophage inflammatory protein 1 in plasma of animals
was determined on days 0, 1, 3, 6, 8, 11, and 14 postinfection by using a
non-human primate cytokine Milliplex map kit (Millipore Corp., Billerica, MA)
as described by the manufacturer. Samples were read by using a Bio-Plex 200
system (Bio-Rad, Hercules, CA).
Virus titration. Tissue samples were placed in RNAlater (Ambion) for sub-
sequent RNA extraction (RNeasy kit; Qiagen). Tissue homogenates (10% [wt/
vol]) were prepared in MEM-bovine serum albumin. Debris was pelleted by
centrifugation (2,000  g, 5 min), and virus titers were determined in 10-fold
dilutions of supernatant by standard TCID50 assay on MDCK cells, in triplicate
for each dilution. Virus titers were similarly determined in blood and swab
suspensions.
Histopathology and immunohistochemistry. Animal tissues were fixed in 10%
phosphate-buffered formalin. Fixed tissues were processed by conventional
methods, embedded in paraffin, cut into 5-m-thick sections, and stained with
standard hematoxylin and eosin. Slides for immunohistochemistry were stained
by using the Discovery XT and DAB map kit from Ventana Medical Systems
(VMS), Tucson, AZ. The polyclonal SOIV (H1N1) hemagglutinin (HA) anti-
body (ProSci., Inc., Poway, CA) was diluted in antibody dilution buffer (VMS) at
1:500, followed by incubation for 32 min. Next, a biotinylated secondary of goat
anti-rabbit SS Link (Biogenex, San Ramon, CA) was incubated for 32 min,
followed by enzyme conjugate, and diaminobenzidine. Slides were counter-
stained with hematoxylin, dehydrated, cleared in xylene, and coverslipped.
Microarray analysis. Microarray analysis was performed using Agilent rhesus
macaque 444K microarrays using the manufacturer’s one-color analysis pro-
tocol. TaqMan was used to analyze lung samples for the presence of viral RNA.
Because viral RNA was not detected in the sample available for microarray from
animal 2 in the Mex4487 group, this animal was not included in subsequent
transcriptional analyses. Gene expression in individual samples was quantified
relative to gene expression from a pooled sample of lung RNA from seven
uninfected cynomolgus macaques (five females and two males; ages, 7.5 to 12.9
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years; 2.6 to 6.2 kg). Differential gene expression between the groups was iden-
tified at day 1 postinfection using a one-way Textbook analysis of variance
(ANOVA; P 	 0.01) using Rosetta Resolver (Rosetta Biosoftware). To filter
gene sequence that changed minimally between treatment groups, gene sets from
the ANOVAs were then filtered to include genes that changed as least 2-fold
between any two of the treatment groups. Functional analysis of statistically
significant gene expression changes was performed by using ingenuity pathway
analysis (IPA; Ingenuity Systems), which analyzes gene expression data in the
context of known biological response and regulatory networks. A Fisher exact
test was used to determine the probability that each biological function assigned
to that data set was due to chance alone. Heat maps for gene expression were
created by using Spotfire DecisionSite 9.1.1. All gene expression data described
here are publicly available at http://viromics.washington.edu.
RESULTS AND DISCUSSION
Selection and genetic characterization of SOIV strains. To
determine the virulence of the newly emerged SOIV in a re-
cently established nonhuman primate model (18), we investi-
gated two genetically similar but clinically distinct isolates from
Mexico in comparison with the current seasonal H1N1
influenza virus strain A/Kawasaki/UTK-4/2009 (Kaw). A/Mex-
ico/4108/2009 (Mex4108) and A/Mexico/InDRE4487/2009
(Mex4487) were isolated from human clinical specimens in the
early stage of the pandemic. The two isolates from Mexico
differed only in seven amino acid positions (PB2, amino acid
[aa] 82; PA, aa 275, aa 581; HA aa 444; NP, aa 100, aa 373; and
M2, aa 82) (see Table S1 in the supplemental material) but
were isolated from cases with distinct clinical outcomes
(Mex4108, mild single case; Mex4487, cluster of severe cases).
In comparison to a hypothetical SOIV consensus sequence
based on sequence data from early stage isolates of the pan-
demic, Mex4108 showed unique substitutions in the HA (aa
444), NP (aa 100), and M2 (aa 82) proteins, whereas Mex4487
had unique substitutions in the PB2 (aa 82) and PA (aa 275)
proteins (see Table S1 in the supplemental material). None of
the changes in these isolates, however, involves critical do-
mains/motifs in PB1, PB2, HA, NA, and NS1 that have been
implicated as influenza virulence markers (14, 19, 26, 27, 29,
33, 34), but all acquired the second-site suppressor mutation in
PB2 (Q591R) that conveys enhanced polymerase activity in
human cells (23).
Clinical progression of SOIV infection. Cynomolgus ma-
caques were infected simultaneously via multiple routes (intra-
tracheal, intranasal, ocular, and oral) with a total dose of 7 
106 TCID50 of either Kaw (n  6), Mex4108 (n  6), or
Mex4487 (n  9) using a protocol specifically optimized for
infection with respiratory viruses of both the upper and the
lower respiratory tracts (18). A similar challenge dose for all
groups was confirmed by back titration of each inoculum on
MDCK cells (Kaw, 1.1  106 TCID50/ml; Mex4108, 1.1  10
6
TCID50/ml; and Mex4487, 2 10
6 TCID50/ml). Animals in the
two SOIV-infected groups started to show signs of disease on
days 1 to 2 postinfection with reduced food intake, slightly
elevated temperature (2°F), and mild depression. In subse-
quent days, the animals exhibited reduced activity, piloerec-
tion, and signs of respiratory disease (e.g., increased respira-
tion rate and nasal discharge) (Fig. 1A; see also Table S2 in the
supplemental material). Clinical signs were generally milder
and shorter-lived in Mex4108 compared to the moderate/se-
vere and prolonged disease in Mex4487-infected animals. In
contrast, cynomolgus macaques infected with the seasonal
H1N1 virus (Kaw) showed either mild clinical signs or were
clinically asymptomatic overall (Fig. 1A; see Table S2 in
the supplemental material). Clinical manifestations and dis-
ease progression in Mex4487-infected animals were closer to
those observed for infections with 1918 influenza viruses (same
routes and similar dose), where animals showed very pro-
nounced clinical symptoms early upon infection (days 1 to 2
postinfection) with rapid progression toward severe pneumo-
nia or ARDS (5, 18). However, in contrast to 1918 virus-
infected macaques, none of the SOIV-infected animals suc-
cumbed to the infection. Hematology showed elevated WBCs
on day 1 postinfection for most animals, which was mainly due
to increase in neutrophil numbers (data not shown). This most
likely occurred as a result of infection and was not statistically
significant among the different groups. All tested serum bio-
chemistry parameters stayed within normal ranges.
Respiratory disease development was further examined by
radiographic imaging (X-ray). The first signs of infiltration and
interstitial markings were observed in the lungs of some SOIV-
infected animals on day 1 postinfection. This developed into
mild to moderate interstitial infiltrates and partial cardiac bor-
der effacement with small areas of pulmonary consolidation.
Areas of pulmonary consolidation increased in density and
distribution in the Mex4487-infected animals (Fig. 1B and 2C;
see also Table S2 in the supplemental material). These animals
were more severely affected compared to Mex4108-infected
animals (Fig. 1B and 2B). Kaw-infected animals did not show
any obvious X-ray abnormalities (Fig. 1B and 2A). Radio-
graphic imaging was used to follow disease progression and
allowed the detection of changes that peaked between days 6
and 8 postinfection for Mex4487 (Fig. 1B; see Table S2 in the
supplemental material). In accordance with the severity of
radiological changes, the respiration rate of the Mex4487-in-
fected animals was significantly increased compared to the
Kaw- and Mex4108-infected animals, which showed little to no
X-ray abnormalities (Fig. 1C and 2; Table S2 in the supple-
mental material).
Pathology and histopathology of SOIV infection. Two
(Mex4108) or three (Kaw and Mex4487) animals from each
group were euthanized for necropsy on days 1, 6, and 14
postinfection (Kaw were only euthanized on days 1 and 6). Day
1 specimens were collected to study early disease progression
and host immune responses. Day 6 postinfection was chosen
for maximum pathology and day 14 was chosen to examine
recovery from infection. We did not find clear evidence of
virus-associated gross pathology in any of the groups 1 day
after infection (Fig. 1D). The Kaw-infected group did not show
any obvious gross pathology changes on either day 1 or 6
postinfection (Fig. 1D and 2A). In contrast, gross pathology
was noted in both SOIV-infected groups on day 6 and was
particularly pronounced in the animals infected with Mex4487,
which developed more widely distributed and larger lung le-
sions (Fig. 1D; Fig. 2B and C). Specifically, affected lung lobes
of animals infected with Mex4487 appeared dense with visible
fluid exudates, indicating edema, and were plum colored and
firm on palpation (Fig. 2C). Pulmonary lesions noted in an-
imals infected with Mex4108 were characterized by multifo-
cal, smaller, circumscribed, red areas and firm lung paren-
chyma (Fig. 2B). Mex4487-infected animals showed
prolonged lung gross pathology at day 14 postinfection, a
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finding suggestive of extended virus replication in Mex4487-
infected animals (Fig. 1D).
Histologic changes on day 1 postinfection in lungs from the
SOIV-infected animals were comparable and interpreted as
multifocal, minimal to moderate, acute pneumonia character-
ized by alveolar and bronchiolar infiltrates of mostly neutro-
phils, fewer macrophages, few lymphocytes, and variable
amounts of hemorrhage (Fig. 3C and E). Multifocal, mild
alveolar and bronchiolar edema, occasional alveolar fibrin,
multifocal degeneration and necrosis of bronchiolar epithe-
lium, and multifocal perivascular lymphocytic infiltrates were
also noted (Fig. 3C and E). In contrast, changes in the lungs
from Kaw-infected animals were primarily characterized by
minimally increased numbers of neutrophils in alveolar septae
and mild alveolar histiocytosis with multifocal, mild lympho-
histiocytic perivasculitis, and, occasionally, low numbers of
neutrophils and macrophages within the lumen of bronchioles
(Fig. 3A). Immunohistochemical (IHC) staining for viral HA
antigen of SOIV-infected lungs on day 1 postinfection revealed
moderately abundant antigen positivity in alveolar epithelium
and less frequent staining of bronchiolar epithelium. HA-spe-
cific staining was also observed in alveolar luminal cells, which
were interpreted as sloughed alveolar epithelial cells, alveolar
macrophages, or both (Fig. 3D and F). In contrast, only rare,
single alveolar epithelial cells and macrophages were viral an-
tigen positive in lung samples from Kaw-infected animals on
day 1 postinfection (Fig. 3B).
Lung histopathology from SOIV-infected animals necrop-
sied on day 6 postinfection were similar and interpreted as
mild to severe subacute to chronic pneumonia characterized by
alveolar edema, fibrin, extensive type II alveolar pneumocyte
hyperplasia and occasional hyaline membrane formation (Fig.
3I and K). There were numerous macrophages, neutrophils,
and lymphocytes, with variable amounts of edema and fibrin
within alveolar and bronchiolar lumina, and alveolar septae
were expanded by similar inflammatory components. Multifo-
cal perivascular lymphohistiocytic and eosinophilic inflamma-
tion was also noted (Fig. 3I and K). In contrast, only minimal
alveolar and bronchiolar inflammation was noted in lungs from
the Kaw group necropsied at day 6 postinfection (Fig. 3G).
Histopathological changes were characterized by multifocal,
mild accumulations of macrophages with microvesicular,
foamy cytoplasm within alveoli and bronchiolar lumina, and
multifocal perivascular infiltrates of lymphocytes and macro-
phages (Fig. 3G). IHC staining of lung tissue for the presence
of HA antigen on day 6 postinfection was comparable in the
Kaw- and Mex4108-infected animals (Fig. 3H and J) with onlyFIG. 1. Disease progression of infected cynomolgus macaques.
Cynomolgus macaques were infected with a total dose of 7  106
TCID50 of either Kaw (blue), Mex4108 (green), or Mex4487 (red) as
described in Materials and Methods. (A) Clinical scoring. The scoring
for clinical symptoms is described in Materials and Methods and in the
legend to Table S2 in the supplemental material. Clinical scores were
high and symptoms were prolonged in animals infected with Mex4487.
The Mex4108-infected animals showed initial transient clinical symp-
toms, whereas the Kaw-infected animals were largely asymptomatic.
(B) Radiographic scoring. The scoring for radiographic changes is
described in Materials and Methods. The scores were higher for ani-
mals infected with Mex4487-infected animals compared to Mex4108-
and Kaw-infected animals. Grading scheme: grade 0, normal exami-
nation; grade 1, mild interstitial pulmonary infiltrates; grade 2,
moderate interstitial pulmonary infiltrates, may include partial cardiac
border effacement, small areas of pulmonary consolidation; grade 3,
pulmonary consolidation as primary lung pathology often seen as pro-
gression from grade 2 lung pathology. (C) Respiration rate. The res-
piration rate was determined during clinical examinations and is pre-
sented as breaths per minute. Respiration was increased for the
Mex4487-infected animals only. (D) Gross pathology scoring. The
lungs were visually inspected during necropsy and percentage scores (0
to 100%) for damage of lung tissue were assigned to the different lung
lobes (upper, middle caudal). The average scores for both lungs are
shown. Lung lesions peaked on day 6 postinfection and were highest
for Mex4487-infected animals. A notable degree of lesion area in lungs
of the Mex4487-infected animals was observed on day 14 postinfection.
Error bars represent the standard errors of the mean.
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rare staining of macrophages and alveolar epithelial cells. An-
tigen-positive cells were notable and observed more frequently
in the Mex4487-infected lung sections at day 6 postinfection
(Fig. 3L), indicating prolonged replication of this isolate in
lung tissue, as was suggested by the presence of gross pathology
lesions (Fig. 1D). By day 14 postinfection, small clusters of
antigen positive cells were observed, though rarely, in the
Mex4487-infected lung sections, but not in the Mex4108-in-
fected sections (data not shown). Overall, the histopathological
features described here are comparable with influenza virus
infections in humans (11, 21, 38) and have been reported in
animal models of severe acute respiratory syndrome coronavi-
rus (32).
Overall, lung pathology was different between the two SOIV
isolates with multifocal small versus large pronounced and
widely distributed affected areas in Mex4108- and Mex4487-
infected animals, respectively (Fig. 1D; Fig. 2B and C). How-
ever, lung histopathology of selected affected areas did not
reveal major differences between the two SIOV isolates (Fig.
3). In contrast, Kaw-infected animals showed nearly no gross
lung pathology and histopathological changes were focal and
less pronounced (Fig. 1D, Fig. 2, and Fig. 3).
Extent of SOIV replication. All three viruses (Kaw,
Mex4108, and Mex4487) were detected to similar high titers in
upper and lower respiratory tract tissues on day 1 postinfection
(Fig. 4A). Sustained replication in lower respiratory tract tissue
could only be found with Mex4487, with similar titers on days
1 and 6 postinfection (Fig. 4A and B). There was no evidence
for systemic spread of any of the viruses as indicated by the
absence of viremia and nondetectable virus titers in other
selected organs (for a list of tested organs, see Materials and
Methods).
In vitro growth in human lung carcinoma cells (A549)
showed similar growth kinetics within the first 48 h for both
SOIVs and Kaw, supporting in vivo data obtained on day 1
postinfection (Fig. 4A and C). In contrast, later in infection
(day 3 postinfection), Mex4487 showed an in vitro replication
advantage with titers 1 log higher compared to Mex4108 and
FIG. 2. Radiological and gross pathological examination of the lungs of infected cynomolgus macaques. Cynomolgus macaques were infected
as described in Materials and Methods with a total dose of 7  106 TCID50 of either Kaw (A), Mex4108 (B), or Mex4487 (C). The radiographic
images (X-ray) shown are of a representative animal from each group. Images were taken from the same animal at day 1, prior to infection, and
at day 6 postinfection (postmortem). Extensive lung infiltrations were seen on day 6 X-ray image for Mex4487, whereas Mex4108 and Kaw showed
little to no infiltrations. Accordingly, extensive lesions were visible in the lungs of the animals infected with Mex4487 on day 6 postinfection. The
asterisk (*) indicates a localized lesion in the caudal right lobe of a Mex4108-infected animal.
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Kaw (Fig. 4C), consistent with the prolonged in vivo replication
of this isolate in lung tissue (Fig. 4B).
We further analyzed infectivity of mucosal membranes as an
indicator for virus shedding and a potential marker for trans-
FIG. 3. Histological examination of lungs of infected cynomol-
gus macaques. Cynomolgus macaques were infected as described in
Materials and Methods, with a total dose of 7  106 TCID50 of
either Kaw, Mex4108, or Mex4487. Hematoxylin and eosin (H&E)
and immunohistochemistry (IHC; anti-HA antigen)-stained sec-
tions of lungs from cynomolgus macaques necropsied at day 1
postinfection (A to F) and day 6 postinfection (G to L) are shown.
At day 1 postinfection, there was neutrophilic exudate within the
lumen of bronchioles and necrosis and loss of bronchiolar epithe-
lium in the lungs of SOIV-infected animals (* and open arrowhead,
respectively, panels C and E) and only minimal inflammation noted
in Kaw-infected lungs (A). At day 6 postinfection, there was exten-
sive alveolar edema, fibrin and type II alveolar pneumocyte hyper-
plasia in the lungs of SOIV-infected animals (e and f, arrowhead,
respectively, panels I and K). IHC (anti-HA antigen) is demon-
strated in alveolar epithelial cells (white arrowhead), bronchiolar
epithelial cells (open arrow), and macrophages (black arrow) (B, D,
F, H, J, and L).
FIG. 4. Virus replication in the upper and lower respiratory tracts
as well as tissue culture. Cynomolgus macaques were infected as de-
scribed in Materials and Methods with a total dose of 7  106 TCID50
of either Kaw (blue), Mex4108 (green), or Mex4487 (red). Virus titers
were determined by TCID50 assay from tissue specimens collected
during necropsies on day 1 (A) and 6 (B) postinfection. (C) Growth
kinetics of the different viruses in A549 cells over 72 h. Error bars
represent the standard errors of the mean.
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mission. Throughout the experiment oral and rectal swabs
remained negative for infectious virus (data not shown). Virus
detection in nasal swabs was inconsistent and ranged from 0 to
50% of the infected animals being positive in each group.
Interestingly, with some Mex4108-infected animals virus could
be detected in nasal swabs for up to day 8 postinfection,
whereas virus seemed to be cleared from Mex4487- and Kaw-
infected animals by day 6 (data not shown). Further studies are
needed to address this important epidemiological marker of
SOIVs and its implication for public health, but the prelimi-
nary data here might suggest a potential difference in trans-
missibility among SOIV isolates. In that regard, two previous
transmissibility studies in ferrets reported contradictory re-
sults, with one group reporting similar transmissibility (24) and
the other reporting a less efficient transmissibility (22) when
comparing a single SOIV isolate with seasonal H1N1 viruses.
Host transcriptional responses to SOIV infection. To ex-
plore the early transcriptional responses to infection with the
two SOIV isolates, we performed microarray analysis on lung
samples taken at necropsy on day 1 postinfection. ANOVA
revealed 788 gene expression differences that distinguished the
isolates (Fig. 5; see Table S3 in the supplemental material).
The greatest number of expression differences was between
Kaw and Mex4487, whereas differences between the SOIV-
infected animals were more subtle (see Table S4 in the sup-
plemental material). IPA was used to evaluate the biological
pathways associated with these differences in transcription.
Inflammatory response was among the top biological catego-
ries of genes that distinguished the groups at day 1 postinfec-
tion (Fig. 6A; see Table S5 in the supplemental material). The
inflammatory response genes represented were most signifi-
cantly related to immune response, cell activation, cell move-
ment, and phagocytosis, with many of the genes within this
category playing roles in more than one biological function.
Examination of expression patterns of these genes suggested
the most robust induction of genes within the Mex4487-in-
fected animals, with the Mex4108 strain exhibiting an interme-
diate expression phenotype between those of Mex4487 and
Kaw. In contrast, a decrease in expression was observed for
many of these genes in the Kaw animals. Intracellular NF-
B
signaling molecules were upregulated to the greatest extent in
the Mex4487-infected animals (Fig. 6B). This upregulation was
concurrent with a robust induction of directly related cytokine/
chemokine and antigen presentation molecules. These differ-
ences in response were less pronounced in the Mex4108-in-
fected animals and relatively rare in the Kaw-infected animals.
Given the similarities in virus titer in the lung at day 1 postin-
fection (Fig. 4), these differences in host response cannot be
attributed solely to viral levels in the lung. The greater expres-
sion of genes in response to the SOIV strains compared to the
Kaw isolate is in agreement with the greater infiltration of
immune cells into the lung at day 1 postinfection (Fig. 3) and
is predictive of the greater tissue damage observed in the lungs
at day 6 postinfection (Fig. 1D and 2).
Proinflammatory cytokine levels after SOIV infection. To
further investigate the differences in inflammation noted in the
transcriptional data, we analyzed the levels of selected inflam-
matory mediators in the blood of SOIV-infected animals. We
observed increased, early systemic inflammatory responses fol-
lowing infection with the Mex4487 strain that was less pro-
nounced in animals infected with Mex4108 or Kaw isolates. In
particular, plasma cytokine analysis revealed the greatest in-
crease in the levels of IL-6 and MCP-1 in the Mex4487-in-
fected animals early after infection (Fig. 7). The increased
levels of proinflammatory plasma cytokines were in accord
with the increase in inflammatory gene expression observed in
the lungs of SOIV-infected animals at day 1 postinfection
compared to Kaw-infected animals (Fig. 5; see Table S6 in the
supplemental material). In particular, greater IL-6 gene ex-
pression was also observed in the lungs of Mex4487-infected
animals on day 1 postinfection, with intermediate and low
levels for the Mex4108- and Kaw-infected groups, respectively.
The trends observed for IL-6 gene expression in the lungs were
similar to expression patterns for the proinflammatory cyto-
kines TNF- and IL-1 (see Table S6 in the supplemental
material). Severe influenza virus infection is associated with
increased early and prolonged inflammatory responses (7, 8,
18), and increased protein levels of IL-6 have also been re-
ported in response to infection with more virulent H1N1
strains in ferrets (37), severe 1918 infections in macaques (18),
FIG. 5. Differential host transcriptional responses. Cynomolgus
macaques were infected as described in Materials and Methods with a
total dose of 7  106 TCID50 of either Kaw, Mex4108, or Mex4487.
The animals were euthanized on day 1 postinfection, and the total
RNA was isolated from lung tissue. The figure shows one-dimensional
clustering of genes with statistically different expression in the lung at
day 1 postinfection (788 gene sequences; see Table S3 in the supple-
mental material) as determined by one-way ANOVA (P  0.05, se-
lecting for sequences that were 2-fold different between at least two of
the treatments). Clustering of expression data for each animal was
performed by using hierarchical unweighted pair-group method with
arithmetic mean (UPGMA) with Euclidean distance similarity mea-
sure using an average value ordering function. The dendrogram at the
top of the heat map indicates the overall similarities in gene expression
between the individual animals. The dendrogram on the left side of the
heat map indicates the similarities in expression between the differen-
tially expressed genes. On the right side of the heat map, two major
groups are indicated in orange (563 gene sequences) and blue (225
gene sequences). Gene expression for an animal is shown as the log(ra-
tio) of expression relative to a common reference pool of RNA ex-
tracted from lungs of uninfected cynomolgus macaques. Red indicates
that the gene expression is higher than the uninfected reference; green
indicates that gene expression is lower than the uninfected reference
sample.
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and a fatal human case of SOIV (25), but not from infections
with contemporary H1N1 viruses in macaques (18). IL-6 levels
have also been associated with mediating the clinical manifes-
tation of influenza virus infections in humans (15, 35), and thus
may be an indicator for progression to more severe disease
caused by influenza viruses.
The plasma levels of MCP-1 were significantly higher in
Mex4487-infected animals on day 1 postinfection compared to
those observed in Mex4108- and Kaw-infected animals (Fig. 7).
Gene expression of MCP-1 was upregulated in the lungs at day
1 postinfection in all groups, with the greatest transcriptional
response in animals infected with Mex4487. Elevated MCP-1
levels were also found in sera of 1918 virus-infected macaques
(18) and the sera and lung tissues of a fatal human SOIV case
FIG. 6. Differential host transcriptional responses of inflammatory response-related genes. (A) One-dimensional clustering of genes in relation
to inflammatory response. The average expression for each animal is shown as the log(ratio) of expression relative to a common reference pool
of RNA extracted from lungs of uninfected cynomolgus macaques. Red indicates that the gene expression is higher than the uninfected reference;
green indicates that gene expression is lower than uninfected reference sample. Clustering of expression data for each animal was performed by
using hierarchical UPGMA with a Euclidean distance similarity measure using an average value ordering function. The association of each
molecule within the biological pathways (right) is shown, with blue denoting an association with the pathway and gray denoting no association with
the select pathway. (B) Network diagram depicting the relationship between NF-
B signaling molecules (shown in light blue), antigen presentation
(shown in yellow), and cytokine/chemokine-related molecules (shown in red). Molecules in the network were selected from differentially regulated
inflammatory response genes based on their direct interactions with each other, as determined by functional analysis performed using IPA
(Ingenuity Systems).
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(25). In contrast, IL-8 responses were significantly higher in
Mex4108-infected animals, similar to ferrets infected with less-
virulent H1N1 viruses (37). Overall, the induction of the proin-
flammatory response was not as pronounced with Mex4108
and the seasonal Kaw virus, which behaved similarly to what
was described previously for the seasonal human A/Kawasaki/
173/01 (H1N1) (18) and A/Texas/36/91 (H1N1) (2, 4) isolates.
Conclusions. The two SOIV isolates caused mild to severe
pneumonia in the cynomolgus macaque model demonstrating
a higher virulence than the seasonal H1N1 isolate (Kaw). Clin-
ical signs following SOIV infection ranged from mild to severe
and were more advanced over the relatively mild infections
caused by seasonal influenza viruses such as Kaw (Fig. 1A; see
Table S2 in the supplemental material), A/Kawasaki/173/01
(H1N1), and A/Texas/36/91 (H1N1) (2, 4, 18). Pathological
and radiological changes observed with the SOIV isolates were
in accordance with moderate to severe interstitial pneumonia
(Fig. 2 and 3) and were also more severe than those observed
with the above-mentioned seasonal influenza virus strains (2, 4,
18). Overall, these findings assign the newly emerged SOIV
isolates to an intermediate virulence phenotype in macaques
between seasonal influenza and the more severe infections
caused by the highly virulent H5N1 (5, 31) and 1918 H1N1 (18)
viruses.
The striking heterogeneity in virulence in the cynomolgus
macaque model between SOIV isolates is particularly interest-
ing given that the isolates are two genetically similar strains
and are derived from the same geographical region during the
early stage of the pandemic. The Mex4487 isolates caused
more severe pneumonia with prolonged replication in the
lower respiratory tract (Fig. 1 to 4; see Table S2 in the supple-
mental material). This differs from contemporary seasonal hu-
man H1N1 influenza virus strains that are characterized in this
animal model by a short-term virus presence, mainly in the
upper respiratory tract (2, 4, 18, 38) or, if inoculated intratra-
cheally, by rapid clearance from lung tissue (Fig. 4A and B).
This observation could be due in part to differences in virus
replication as Mex4487 replicated to higher titers and over a
prolonged period in human lung carcinoma cells (A549) (Fig.
4C). Some distinct features of individual SOIV isolates ob-
served in the present study might be controlled by differences
in in vivo replication and/or host responses which could be
associated with certain amino acid substitutions (see Table S1
in the supplemental material). However, no distinct molecular
motifs have been described for SOIV H1N1 isolates, in con-
trast to the virulence markers identified in H5N1 and 1918
H1N1 viruses (14, 19, 26, 27, 29, 33, 34). We have started to
analyze the impact of the mutations found between the
Mex4108 and Mex4487 strains (see Table S1 in the supplemen-
tal material) using reverse genetics. It will be critical to identify
molecular fingerprints associated with a pathogenic phenotype
to support future patient management and public health re-
sponses.
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